
USD $1464.00
Orgonist 120 mg Tablet is a prescription androgen‑deprivation therapy used in adult men with advanced or metastatic hormone‑sensitive prostate cancer. It contains Relugolix, an oral GnRH receptor antagonist that rapidly and sustainably lowers testosterone levels to help slow or stop prostate cancer growth.
Orgonist 120 mg Tablet is a prescription medicine used in adult men to treat advanced or metastatic prostate cancer.
It contains Relugolix, an oral gonadotropin‑releasing hormone (GnRH) receptor antagonist that lowers testosterone levels to slow or stop cancer growth.
Orgonist is indicated for adult men with hormone‑sensitive prostate cancer, including advanced or metastatic disease, as part of androgen‑deprivation therapy.
It is not intended for use in women, children, or adolescents, and should not be used in pregnancy or breastfeeding.
Relugolix in Orgonist blocks GnRH receptors in the pituitary gland, reducing the release of LH and FSH, which in turn significantly reduces testosterone production in the testes.
Since most prostate cancer cells depend on testosterone to grow, this sustained testosterone suppression helps control the disease and its symptoms.
Treatment is usually started with a higher loading dose of Relugolix on day one, followed by one 120 mg tablet taken once daily at about the same time each day, with or without food, as directed by your specialist.
Swallow the tablet whole with water; do not crush, chew, or split it unless your doctor specifically advises otherwise.
Orgonist 120 mg Tablet can be taken with or without food.
Choose a routine (for example, after breakfast) and take it the same way each day to maintain consistent blood levels.
If you miss a dose and it has been less than 12 hours since your usual time, take it as soon as you remember that same day.
If more than 12 hours have passed, skip the missed dose and take your next tablet at the regular time; do not double the dose to make up for a missed tablet.
Duration of therapy depends on your cancer stage, treatment goals, and whether it is combined with radiotherapy or other treatments, and is decided by your oncologist or urologist.
Many men remain on androgen‑deprivation therapy for months to years, with regular review of PSA, testosterone, symptoms, and side effects.
Commonly reported side effects include:
Seek urgent medical attention if you experience chest pain, shortness of breath, palpitations, severe dizziness or fainting, which may indicate heart rhythm or cardiovascular problems.
Also report sudden weakness, confusion, severe headache, severe mood changes, or signs of an allergic reaction such as facial swelling, rash with breathing difficulty, or throat tightness.
Tell your doctor if you have a history of heart disease, stroke, high blood pressure, abnormal heart rhythm, or risk factors for QT prolongation, as Relugolix can affect cardiac electrical activity.
Inform your doctor about osteoporosis or bone disease, liver or kidney problems, diabetes or pre‑diabetes, or any electrolyte disturbances so that monitoring and supportive measures can be planned.
Long‑term testosterone suppression can reduce bone mineral density and may increase the risk of osteoporosis and fractures in some men.
Your doctor may recommend bone health strategies, such as calcium and vitamin D, lifestyle measures, or bone‑protective medications, depending on your fracture risk.
Orgonist can cause reduced libido, erectile dysfunction, and potential male fertility problems while on treatment, because it significantly lowers testosterone.
If you are planning to father a child, discuss sperm banking or contraception and family‑planning options with your doctor before starting therapy.
No, Orgonist 120 mg Tablet is not indicated for use in women and must not be used during pregnancy or breastfeeding as it may harm the unborn or breastfed baby.
If exposure occurs, medical advice should be sought immediately.
The effect of alcohol with Orgonist is not fully established; however, caution is advised because both alcohol and androgen‑deprivation therapy can contribute to tiredness, dizziness, or liver strain.
Discuss your alcohol intake with your doctor, especially if you have liver disease or other risk factors.
It is not clearly known whether Orgonist directly affects driving ability, but side effects such as fatigue, dizziness, or sleep disturbance can impair concentration.
Avoid driving or operating heavy machinery if you feel unwell, dizzy, or unusually tired while on treatment.
There is no specific mandatory diet for Orgonist, and it can be taken with normal meals.
A balanced diet, limiting junk and high‑fat foods and including fibre‑rich options can help manage side effects such as weight gain and constipation.
Yes, your doctor will usually monitor your PSA and testosterone levels to assess how well the treatment is working.
Blood tests may also be done periodically to check liver function, blood counts, glucose, lipids, and electrolytes, and to adjust treatment if needed.
Relugolix can alter certain blood and liver test results, so it is important to inform the laboratory and your doctor that you are taking Orgonist before tests are done.
This helps your healthcare team correctly interpret results and decide if any changes are needed.
Orgonist (Relugolix) is affected by and can affect certain other medicines, particularly strong P‑gp inhibitors or inducers and some CYP3A modulators, which can change its blood levels.
Always tell your doctor and pharmacist about all prescription, over‑the‑counter, herbal, and supplement products you use so they can check for interactions and adjust therapy or timing if needed.
Do not take Orgonist if you are allergic to Relugolix, sodium, or any other ingredient in the tablet.
It should be avoided or used with great caution in people with certain severe underlying conditions unless a specialist decides that the benefits outweigh the risks.
There is no evidence that Orgonist is habit forming or addictive.
However, it must only be taken under medical supervision, and you should not share it with anyone else.
Orgonist 120 mg is usually supplied as a strip or blister pack of oral tablets for once‑daily use, often in packs of 10 or similar depending on the manufacturer and market.
Packaging details such as exact pack size and appearance may vary between pharmacies and regions.